Media Outlet: Spectrum News' In Focus Texas
11/3/2024- According to research from major health institutions, 60% of men in the U.S. skip preventive doctor visits. Srinath Kotamarti, M.D., of Texas Urology Specialists–DeSoto joined Spectrum News’ “In Focus Texas” to explore factors that heighten cancer risk, ways men can take charge of their health, and why open conversations with a healthcare provider are essential.
Media Outlet: Brighter Magazine
10/1/2024- Multiple studies have shown that meditation and journaling can improve mental and physical health and overall quality of life when used within an integrative health approach. Breana Mobley, LMSW, Texas Oncology–Baylor Charles A. Sammons Cancer Center, explains the benefits of meditation and journaling for cancer patients and survivors.
Media Outlet: Significant progress has been made since the approval of the first CAR T-cell therapy, but there is still tremendous room for improvement.
7/10/2024- Significant advancements in chimeric antigen receptor (CAR) T-cell therapy have occurred over the past several years as successful clinical trials and FDA approvals have positively impacted patient outcomes. Houston Holmes, MD, MBA, hematologist and medical oncologist at Texas Oncology–Baylor Charles A. Sammons Cancer Center shares the barriers and solutions to CAR-T therapy and what community oncologists do to optimize CAR T-cell therapy for their patients with cancer.
Media Outlet: D Magazine
6/17/2024- Andrew K. Lee, M.D., MPH, radiation oncologist and medical director at the Texas Center for Proton Therapy, joined a panel of experts to discuss the role of employers in the healthcare ecosystem, the risks and benefits of continued consolidation in the industry, the impacts of artifical intelligence, and the importance of price transparency, among other topics.
Media Outlet: KERA News (NPR, North Texas)
4/22/2024- Dallas and Austin are part of a worldwide clinical trial underway to find a more effective treatment to lower the recurrence of melanoma or high-risk skin cancer. KERA’s Sam Baker talks with Charles Lance Cowey, M.D., medical oncologist at Texas Oncology–Baylor Sammons Cancer Center and an investigator on the studies for the melanoma vaccine.
Media Outlet: D Magazine
2/14/2024- Texas Center for Proton Therapy has been serving cancer patients in Dallas-Fort Worth and beyond for eight years, providing leading-edge patient care by not only ridding patients of cancer, but maximizing their quality of life during treatment and beyond — even decades later.
12/21/2023- As we approach the end of another year of great progress and promise in cancer care, I am as hopeful and optimistic as ever. The rapid pace of new breakthroughs continues while our ability to deliver high quality care in communities across Texas is expanding and improving with new facilities and innovations in treatment such as genetics- and data-informed precision medicine.
Media Outlet: Houston Medical Times
12/7/2023- Carrum Health, a value-based Centers of Excellence healthcare solution changing how we pay for and deliver cancer and surgical care, and Texas Oncology, announce a new collaboration to provide high-quality, cost-effective breast cancer care to patients.
Media Outlet: Texas Monthly
12/1/2023- Texas Center for Proton Therapy is the first and only proton therapy center in Dallas-Fort Worth and the most technologically advanced cancer treatment option in the region, with three pencil-beam scanning proton machines and the ability to do volumetric on-board cone-beam CT imaging when a patient is on the treatment table. Any patient who has been told that they need radiation therapy should look into proton therapy as an option for primary treatment or in combination with other therapies.
Media Outlet: D Magazine
12/1/2023- For eight years, North Texas has had an advantage in the fight against cancer by having Texas Center for Proton Therapy in its own backyard, and as of fall 2023, the center has treated more than 4,000 new patients. Any solid tumor that requires radiation as a treatment component could likely be treated with proton therapy—brain, head and neck, lung, prostate as well as other gastrointestinal and genitourinary cancers.